Panacea Biotec launches generic diabetes treatment drug in India

Panacea Biotec launches generic diabetes treatment drug in India The four formulations are Vildagliptin 50 mg, Vildagliptin 50 mg Metformin HCL 500 mg, Vildagliptin 50 mg Metformin HCL 850 mg and Vildagliptin 50 mg Metformin HCL 1,000 mg, Panacea Biotec said in a filing to the BSE.

No comments:

Post a Comment